Back to RPRX
Goehring & Rozencwajg Associates, LLC → RPRX
Goehring & Rozencwajg Associates, LLC RPRX Position History
Royalty Pharma plc
Quarters held
4
Latest value
$116.5M
Q3 2026
Peak value
$118.1M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $36M |
| Q1 2026 | $118.1M |
| Q2 2026 | $114.1M |
| Q3 2026 | $116.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $116.5M | 2.39M | — | — |
| Q2 2026 | $114.1M | 2.45M | — | — |
| Q1 2026 | $118.1M | 2.30M | — | — |
| Q4 2025 | $36M | 937.0K | — | — |